Arena Pharma (ARNA) Misses Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. ALHC
6. HUM
7. STZ
8. CMG
9. ORCL
10. AAPL

Go back to Arena Pharma (ARNA) Misses Q2 EPS by 1c

Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2018 Financial Results

August 6, 2018 4:01 PM EDT

SAN DIEGO, Aug. 6, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the second quarter ended June 30, 2018.

"We have made significant progress over the past three months across our clinical programs, including the initiation of our ADVANCE Phase 3 program for ralinepag in patients with PAH. We are excited for the opportunity to potentially advance the treatment paradigm for patients suffering from this critical... More